Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
Montesarchio V, Parrela R, Iommelli C, Bianco A, Manzillo E, Fraganza F, Palumbo C, Rea G, Murino P, De Rosa R, Atripaldi L, D'Abbraccio M, Curvietto M, Mallardo D, Celentano E, Grimaldi AM, Palla M, Trojaniello C, Vitale MG, Million-Weaver SL, Ascierto PA.
Montesarchio V, et al. Among authors: palumbo c.
J Immunother Cancer. 2020 Aug;8(2):e001089. doi: 10.1136/jitc-2020-001089.
J Immunother Cancer. 2020.
PMID: 32784217
Free PMC article.